Gastrointestinal cancer is among the most frequent cancers. In our section we treat cancer of the esophagus, stomach, liver, pancreas, colon, rectum and anal canal, in addition to neuroendocrine cancer.
Our research has a broad range from epidemiology, multidisciplinary research, clinical trials, translational research, quality of life, and late effects, within all areas of gastrointestinal cancer.
Group members are active in the tumour-specific groups at Norwegian Gastrointestinal Cancer Group (ngicg.no) and in developing national treatment guidelines.
The colorectal group is part of the K.G. Jebsen Colorectal Cancer Research Centre (colorectal.no).
|Hepatobiliary cancer:||Olav F. Dajani|
|Colorectal and anal cancer:||Marianne Grønlie Guren|
|Neuroendocrine cancer:||Geir Olav Hjortland|
|Cancer unknown primary:||Maria Thomsen|
|Esophageal and gastric cancer||Ghazwan Al-Haidari|